1. Home
  2. ACIU
  3. ACIU News

Latest AC Immune SA (ACIU) News on November 28, 2025

AC Immune to Present at the Jefferies 2025 London Healthcare Conference
ACIU

GlobeNewswire

17 days ago

AC Immune to Present at the Jefferies 2025 London Healthcare Conference

AC Immune (ACIU): Losses Narrow 5.9% Annually; Revenue Growth Forecast at 55.6% Pre-Earnings
ACIU

Simply Wall St.

24 days ago

AC Immune (ACIU): Losses Narrow 5.9% Annually; Revenue Growth Forecast at 55.6% Pre-Earnings

AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
ACIU

Zacks

24 days ago

AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates

ACIU

Associated Press Finance

24 days ago

AC Immune: Q3 Earnings Snapshot

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

24 days ago

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

AC Immune And 2 Other Promising Penny Stocks
ACIU

Simply Wall St.

a month ago

AC Immune And 2 Other Promising Penny Stocks

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
ACIU

GlobeNewswire

a month ago

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine

Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?
ACIU

Zacks

2 months ago

Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?

Why AC Immune (ACIU) Is Up 15.8% After Promising Early Trial Data for Alzheimer’s Vaccine Candidate
ACIU

Simply Wall St.

2 months ago

Why AC Immune (ACIU) Is Up 15.8% After Promising Early Trial Data for Alzheimer’s Vaccine Candidate

A Look at AC Immune’s (NasdaqGM:ACIU) Valuation After New Alzheimer’s Immunotherapy Trial Results
ACIU

Simply Wall St.

2 months ago

A Look at AC Immune’s (NasdaqGM:ACIU) Valuation After New Alzheimer’s Immunotherapy Trial Results

June 2025 Penny Stocks With Promising Potential
ACIU

Simply Wall St.

6 months ago

June 2025 Penny Stocks With Promising Potential

AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates
ACIU

Zacks

7 months ago

AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates

ACIU

Associated Press Finance

7 months ago

AC Immune: Q1 Earnings Snapshot

AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

7 months ago

AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Individual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last week
ACIU

Simply Wall St.

7 months ago

Individual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last week

AC Immune reports interim outcomes from trial of Parkinson’s therapy
ACIU

Clinical Trials Arena

8 months ago

AC Immune reports interim outcomes from trial of Parkinson’s therapy

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
ACIU

GlobeNewswire

8 months ago

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
ACIU

GlobeNewswire

8 months ago

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?
ACIU

Zacks

8 months ago

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago
ACIU

Simply Wall St.

8 months ago

AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

9 months ago

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know
ACIU

Zacks

9 months ago

AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know

AC Immune to Participate in Upcoming Investor Conferences
ACIU

GlobeNewswire

9 months ago

AC Immune to Participate in Upcoming Investor Conferences

Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)
ACIU

Zacks

9 months ago

Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)

3 US Penny Stocks With Market Caps Over $100M To Consider
ACIU

Simply Wall St.

10 months ago

3 US Penny Stocks With Market Caps Over $100M To Consider

US Penny Stocks Spotlight: AC Immune And Two Others To Consider
ACIU

Simply Wall St.

a year ago

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

High Growth Tech Stocks in the United States
ACIU

Simply Wall St.

a year ago

High Growth Tech Stocks in the United States

AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2
ACIU

TipRanks

a year ago

AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
ACIU

GlobeNewswire

a year ago

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
ACIU

Pharmaceutical Technology

a year ago

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit

AC Immune reports interim results from Phase 2 trial of ACI-7104.056
ACIU

TipRanks

a year ago

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

ACIU

MT Newswires

a year ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

ACIU

MT Newswires

a year ago

AC Immune Shares Gain Following Positive Clinical Results of Potential Parkinson's Treatment

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
ACIU

GlobeNewswire

a year ago

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

AC Immune to Present at the Jefferies 2024 London Healthcare Conference
ACIU

GlobeNewswire

a year ago

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates
ACIU

Simply Wall St.

a year ago

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

ACIU

Associated Press Finance

a year ago

AC Immune: Q3 Earnings Snapshot

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

a year ago

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%
ACIU

Simply Wall St.

a year ago

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings
ACIU

GuruFocus.com

a year ago

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

ACIU

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

ACIU

MT Newswires

a year ago

Sector Update: Health Care

ACIU

MT Newswires

a year ago

AC Immune Expects $29 Million Milestone Payment From Janssen

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
ACIU

GlobeNewswire

a year ago

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic
ACIU

Medical Device Network

a year ago

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

ACIU

MT Newswires

a year ago

AC Immune's Partner Life Molecular Gets FDA Fast Track Designation for PET Imaging Agent

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
ACIU

GlobeNewswire

a year ago

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable
ACIU

Simply Wall St.

a year ago

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates
ACIU

Zacks

a year ago

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

ACIU

Associated Press Finance

a year ago

AC Immune: Q2 Earnings Snapshot

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

a year ago

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
ACIU

GlobeNewswire

a year ago

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

ACIU

MT Newswires

a year ago

Sector Update: Health Care Stocks Decline Late Afternoon

ACIU

MT Newswires

a year ago

Sector Update: Health Care

ACIU

MT Newswires

a year ago

AC Immune Shares Surge After Active-Immunotherapy Candidate Gets FDA Fast Track Designation for Alzheimer's Disease

AC Immune wins FDA fast track for Alzheimer’s vaccine
ACIU

Pharmaceutical Technology

a year ago

AC Immune wins FDA fast track for Alzheimer’s vaccine

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
ACIU

GlobeNewswire

a year ago

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024
ACIU

GlobeNewswire

a year ago

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet
ACIU

Simply Wall St.

a year ago

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
ACIU

Zacks

a year ago

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?
ACIU

Simply Wall St.

a year ago

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

ACIU

MT Newswires

a year ago

--BTIG Starts AC Immune With Buy Rating, $8 Price Target

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
ACIU

GlobeNewswire

2 years ago

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company
ACIU

Simply Wall St.

2 years ago

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company

ACIU

MT Newswires

2 years ago

Sector Update: Health Care Stocks Mixed Late Afternoon

ACIU

MT Newswires

2 years ago

Sector Update: Health Care

ACIU

MT Newswires

2 years ago

Top Midday Gainers

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
ACIU

Pharmaceutical Technology

2 years ago

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
ACIU

BioPharma Dive

2 years ago

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

ACIU

MT Newswires

2 years ago

Top Premarket Gainers

ACIU

MT Newswires

2 years ago

Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate

ACIU

Associated Press Finance

2 years ago

AC Immune: Q1 Earnings Snapshot

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

2 years ago

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
ACIU

GlobeNewswire

2 years ago

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
ACIU

Simply Wall St.

2 years ago

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
ACIU

Simply Wall St.

2 years ago

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
ACIU

GlobeNewswire

2 years ago

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

AC Immune Announces Upcoming Presentations at AD/PD™ 2024
ACIU

GlobeNewswire

2 years ago

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
ACIU

Zacks

2 years ago

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023
ACIU

Business Wire

2 years ago

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
ACIU

Zacks

2 years ago

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

4 Best Breakout Stocks to Buy for Superlative Returns
ACIU

Zacks

2 years ago

4 Best Breakout Stocks to Buy for Superlative Returns

5 Relative Price Strength Stocks Compelling Enough to Buy
ACIU

Zacks

2 years ago

5 Relative Price Strength Stocks Compelling Enough to Buy

Best Value Stocks to Buy for January 29th
ACIU

Zacks

2 years ago

Best Value Stocks to Buy for January 29th

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript
ACIU

Insider Monkey

2 years ago

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors
ACIU

Barrons.com

2 years ago

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

ACIU

Reuters

2 years ago

UPDATE 1-Bank of America bonuses for dealmakers, traders are broadly flat -source

Bank of America bonuses for dealmakers, traders are broadly flat -source
ACIU

Reuters

2 years ago

Bank of America bonuses for dealmakers, traders are broadly flat -source

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations
ACIU

Simply Wall St.

2 years ago

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS
ACIU

PR Newswire

2 years ago

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%
ACIU

GlobeNewswire

2 years ago

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest
ACIU

StockStory

2 years ago

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide
ACIU

Food Dive

2 years ago

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
ACIU

GlobeNewswire

2 years ago

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

AC Immune to Regain Global Rights to Crenezumab and Semorinemab
ACIU

GlobeNewswire

2 years ago

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

ACIU

Reuters

2 years ago

CORRECTED-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?
ACIU

Zacks

2 years ago

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
ACIU

Zacks

2 years ago

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why
ACIU

Simply Wall St.

2 years ago

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?
ACIU

Benzinga

2 years ago

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Share on Social Networks: